JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4826
Bridgewater Bancshares
BWB
$572M
| $66K | ﹤0.01% |
6,386
-34,950
| -85% | -$382K |
2018 Q1
4 quarters
|
|
|
DRD
4827
DRDGold
DRD
$2.11B
| $66K | ﹤0.01% |
33,220
+32,246
| +3,311% | +$68.3K |
2018 Q4
1 quarter
|
|
4828
Greif Class B
GEF.B
$4.08B
| $66K | ﹤0.01% |
1,366
-360
| -21% | -$16.4K |
2017 Q4
5 quarters
|
|
4829
Goosehead Insurance
GSHD
$1.09B
| $66K | ﹤0.01% |
2,381
-9,087
| -79% | -$260K |
2018 Q2
3 quarters
|
|
4830
The Joint Corp
JYNT
$102M
| $66K | ﹤0.01% |
+4,190
| New | +$44.3K |
2019 Q1
0 quarters
|
|
4831
American Century Diversified Corporate Bond ETF
KORP
$936M
| $66K | ﹤0.01% |
1,327
-28,157
| -95% | -$1.38M |
2018 Q1
4 quarters
|
|
4832
Option Care Health
OPCH
$3.51B
| $66K | ﹤0.01% |
8,197
-101,331
| -93% | -$1.33M |
2016 Q3
10 quarters
|
|
4833
Invesco International Corporate Bond ETF
PICB
$340M
| $66K | ﹤0.01% |
2,522
| – | – |
2017 Q4
5 quarters
|
|
|
LNAI
4834
Lunai Bioworks
LNAI
$5.3M
| $66K | ﹤0.01% |
+120
| New | +$70.1K |
2019 Q1
0 quarters
|
|
4835
Rockwell Medical
RMTI
$33.7M
| $66K | ﹤0.01% |
105
-5
| -5% | -$2.28K |
2013 Q2
23 quarters
|
|
|
SUP
4836
DELISTED
Superior Industries International
SUP
| $66K | ﹤0.01% |
13,790
-139,015
| -91% | -$744K |
2015 Q4
13 quarters
|
|
|
EVA
4837
DELISTED
Enviva Inc.
EVA
| $66K | ﹤0.01% |
2,040
| – | – |
2018 Q2
3 quarters
|
|
|
DSPG
4838
DELISTED
DSP Group Inc
DSPG
| $66K | ﹤0.01% |
4,695
-44,943
| -91% | -$584K |
2016 Q3
10 quarters
|
|
|
MXWL
4839
DELISTED
Maxwell Technologies Inc
MXWL
| $66K | ﹤0.01% |
14,681
-213,838
| -94% | -$840K |
2017 Q4
5 quarters
|
|
4840
PUT
Prospect Capital
PSEC
$1.06B
| $65K | ﹤0.01% |
+10,000
| New | +$66.5K |
2019 Q1
0 quarters
|
|
4841
Reading International Class A
RDI
$43.5M
| $65K | ﹤0.01% |
4,097
-192
| -4% | -$3.05K |
2016 Q4
9 quarters
|
|
|
GNC
4842
DELISTED
GNC Holdings, Inc.
GNC
| $65K | ﹤0.01% |
23,761
-459
| -2% | -$1.3K |
2013 Q2
23 quarters
|
|
4843
Business First Bancshares
BFST
$1.01B
| $64K | ﹤0.01% |
2,601
-122
| -4% | -$2.93K |
2018 Q2
3 quarters
|
|
|
GDEN
4844
DELISTED
Golden Entertainment
GDEN
| $64K | ﹤0.01% |
4,511
-131
| -3% | -$2.29K |
2017 Q4
5 quarters
|
|
4845
Great Elm Capital Corp
GECC
$69.4M
| $64K | ﹤0.01% |
+1,300
| New | +$63.6K |
2019 Q1
0 quarters
|
|
4846
RBB Bancorp
RBB
$442M
| $64K | ﹤0.01% |
3,388
-1,430
| -30% | -$28.2K |
2017 Q4
5 quarters
|
|
|
ELOX
4847
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $64K | ﹤0.01% |
137
-6
| -4% | -$2.92K |
2018 Q2
3 quarters
|
|
|
KDMN
4848
DELISTED
Kadmon Holdings, Inc.
KDMN
| $64K | ﹤0.01% |
24,326
-1,143
| -4% | -$2.88K |
2018 Q2
3 quarters
|
|
4849
iShares Interest Rate Hedged High Yield Bond ETF
HYGH
$651M
| $63K | ﹤0.01% |
701
| – | – |
2017 Q2
7 quarters
|
|
|
FFNW
4850
DELISTED
First Financial Northwest, Inc
FFNW
| $63K | ﹤0.01% |
3,995
+1,866
| +88% | +$29.4K |
2016 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.